U.S., June 19 -- ClinicalTrials.gov registry received information related to the study (NCT07027722) titled 'Clinical Practices for Treating Severe Malaria Caused by P. Falciparum' on June 11.
Brief Summary: This study looks at how doctors in three hospitals in France treat patients with a serious form of malaria caused by Plasmodium falciparum. It focuses on cases where the level of malaria parasites in the blood is 4% or higher. The study will compare how often a type of medicine called ACT (artemisinin-based combination therapy) is used on its own instead of the usual first-choice treatment (intravenous artesunate), and whether ACT works just as well. It will also check how well patients recover, whether they have complications, and how...